Fund Holdings — Euclidean Capital LLC

Total Portfolio Value
$266.12M
Total Bought
$62.65M
Total Sold
$522.98M
Net Transaction
-$460.33M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
VANGUARD INTL EQUITY INDEX F1,013,4341,991,884+978,45058,181120,82845.40%+62,646
SURROZEN INC(SRZN)170,833170,8330450.00%+1
SURROZEN INC(SRZN)87,69687,69601,2581,0230.38%-236
RAPT THERAPEUTICS INC657,899657,89901,0398030.30%-237
ALECTOR INC1,307,8581,307,85802,4721,6090.60%-863
TENAYA THERAPEUTICS INC(TNYA)1,015,7051,015,70501,4525790.22%-873
PMV PHARMACEUTICALS INC(PMVP)2,627,6432,627,64303,9682,8641.08%-1,104
FOGHORN THERAPEUTICS INC(FHTX)1,573,7611,573,76107,4285,7442.16%-1,684
ORIC PHARMACEUTICALS INC(ORIC)989,410989,41007,9855,5212.07%-2,464
ISHARES TR
MSCI INDIA ETF
2,425,1442,425,1440127,660124,84646.91%-2,813
SPDR S&P 500 ETF TR(SPY)896,2544,104-892,150525,2772,2960.86%-522,981
Page 1 of 1
Euclidean Capital LLC — 13F Holdings — Q1 2025 | TickerTrail